Facebook Live: The Prescription Drug Pricing Pipeline

August 29, 2017

About Insight

Insight provides an in-depth look at health care issues in and affecting California.

Have a story suggestion? Let us know.

Who contributes to what you pay at the pharmacy? Why are prescription drugs so expensive in the United States? In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.

For more in-depth conversations with KHN reporters, check out our Facebook video archive.

Here are videos and a chart to help make sense of drug pricing. And remember you can republish KHN content for free:

Tracking Who Makes Money On A Brand-Name Drug
Sounds Like A Good Idea? Regulating Drug Prices
The Orphan Drug Machine

Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.

This story was produced by Kaiser Health News, an editorially independent program of the Kaiser Family Foundation.

Copy And Paste To Republish This Story

Facebook Live: The Prescription Drug Pricing Pipeline

August 29, 2017

Article HTML

<h1>Facebook Live: The Prescription Drug Pricing Pipeline</h1><p>Who contributes to what you pay at the pharmacy? Why are prescription drugs so expensive in the United States? In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.</p>
	<iframe 
 title="Facebook Live: The Prescription Drug Pricing Pipeline" aria-label="Podcast title: Facebook Live: The Prescription Drug Pricing Pipeline"
		id="wpcom-iframe-aacec0e18ea2ccbc5ceda7419856b219-7618883-82873471"
		width="560"
		height="315"
		src="https://embeds.kff.org/protected-iframe/aacec0e18ea2ccbc5ceda7419856b219-7618883-82873471"
		scrolling="no"
		frameborder="0"
		class="wpcom-protected-iframe"
		>
	</iframe>
	<script type="text/javascript">
		( function() {
			var func = function() {
				var iframe = document.getElementById('wpcom-iframe-aacec0e18ea2ccbc5ceda7419856b219-7618883-82873471')
				if ( iframe ) {
					iframe.onload = function() {
						iframe.contentWindow.postMessage( {
							'msg_type': 'poll_size',
							'frame_id': 'wpcom-iframe-aacec0e18ea2ccbc5ceda7419856b219-7618883-82873471'
						}, "https:\/\/embeds.kff.org" );
					}
				}

// Autosize iframe
				var funcSizeResponse = function( e ) {

var origin = document.createElement( 'a' );
					origin.href = e.origin;

// Verify message origin
					if ( 'embeds.kff.org' !== origin.host )
						return;

// Verify message is in a format we expect
					if ( 'object' !== typeof e.data || undefined === e.data.msg_type )
						return;

switch ( e.data.msg_type ) {
						case 'poll_size:response':
							var iframe = document.getElementById( e.data._request.frame_id );

if ( iframe && '' === iframe.width )
								iframe.width = '100%';
							if ( iframe && '' === iframe.height )
								iframe.height = parseInt( e.data.height );

return;
						default:
							return;
					}
				}

if ( 'function' === typeof window.addEventListener ) {
					window.addEventListener( 'message', funcSizeResponse, false );
				} else if ( 'function' === typeof window.attachEvent ) {
					window.attachEvent( 'onmessage', funcSizeResponse );
				}
			}
			if (document.readyState === 'complete') { func.apply(); /* compat for infinite scroll */ }
			else if ( document.addEventListener ) { document.addEventListener( 'DOMContentLoaded', func, false ); }
			else if ( document.attachEvent ) { document.attachEvent( 'onreadystatechange', func ); }
		} )();
		</script>
	
<p>For more in-depth conversations with KHN reporters, check out our <a href="https://www.facebook.com/pg/KaiserHealthNews/videos/">Facebook video archive</a>.</p>
<p>Here are videos and a chart to help make sense of drug pricing. And remember you can <a href="http://kffhealthnews.org/syndication/">republish KHN content</a> for free:</p>
<ul>
<li><a href="http://kffhealthnews.org/news/tracking-who-makes-money-on-a-brand-name-drug/">Tracking Who Makes Money On A Brand-Name Drug</a></li>
<li><a href="http://kffhealthnews.org/news/sounds-like-a-good-idea-regulating-drug-prices/">Sounds Like A Good Idea? Regulating Drug Prices</a></li>
<li><a href="https://www.youtube.com/watch?v=R98eZrvbGq4">The Orphan Drug Machine</a></li>
</ul>
<p>Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.</p>
<p></p>
<p><em>This story was produced by <a href="http://kffhealthnews.org/">Kaiser Health News</a>, an editorially independent program of the <a href="https://www.kff.org/">Kaiser Family Foundation</a>.</em></p>

We encourage organizations to republish our content, free of charge. Here’s what we ask:

You must credit us as the original publisher, with a hyperlink to our californiahealthline.org site. If possible, please include the original author(s) and “California Healthline” in the byline. Please preserve the hyperlinks in the story.

Have questions? Let us know.

From The California Health Care Foundation

Medi-Cal Medi-Cal Facts and Figures – 2024 Edition

Medi-Cal, California’s Medicaid program, is the state’s health insurance program for Californians with low incomes, including children, people with disabilities, and seniors. Get the latest data on this program, which covers one in three Californians.

Health Policy Survey Health Disparities by Race and Ethnicity in California — 2024 Edition

Disparities among historically marginalized groups in California occur across many demographic categories. This Almanac provides data that show how people of color face barriers in accessing health care, often receive suboptimal treatment, and are most likely to experience poor outcomes in the health care system.

Health Policy Survey The 2024 CHCF California Health Policy Survey

Conducted in fall 2023, this survey collected Californian adults’ opinions and experiences on various health care topics, including mental health, medical debt, racial equity, and more.

Related Topics